组织居民巨细胞膜涂层纳米药物用于向瘤治疗
Xiaodan Su1,2, Mingzhe Su1, Erchu Guo3
1School of Pharmacy, Guangxi Medical University, Nanning 530021, China.
ACS nano
|July 18, 2025
概括
组织寄存型巨细胞为癌症治疗提供了卓越的纳米粒子伪装,增强药物输送和免疫调节. 与传统的M1巨细胞涂层相比,这种仿生方法可以改善血液循环和瘤向.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- 巨细胞膜涂层的纳米粒子 (NP) 在纳米医学中显示出免疫逃避和向传递的前景.
- 目前的系统经常使用M1巨细胞,这些巨细胞可能会促进瘤,并在瘤微环境中面临挑战.
- 组织寄存型巨细胞提供独特的组织特异性定位和免疫调节能力.
研究的目的:
- 审查组织居民巨细胞膜在癌症治疗中纳米粒子功能化的优势和潜力.
- 探索组织巨细胞的起源和免疫调节作用.
- 检查设计这些仿生纳米粒子的策略,以提高治疗效果.
主要方法:
- 文献综述专注于组织居民巨细胞及其在纳米粒子工程中的应用.
- 对纳米粒子伪装生物模拟表面功能化策略的分析.
- 检查巨细胞膜涂层NP的制造技术和治疗前景.
主要成果:
- 组织寄居的巨细胞提供增强的免疫逃避,延长血液循环,并改善瘤向.
- 它们固有的组织特异定位绕过了免疫监测,并准了炎症部位.
- 这些巨细胞具有重要的T细胞免疫调节能力,影响瘤进展.
结论:
- 组织寄居的巨细胞膜代表了瘤治疗中NP的多功能生物仿真涂层.
- 这种方法通过改善药物积累和减少全身毒性来提高治疗疗效和安全性.
- 未来的研究应该集中在这些先进的纳米设备的工程策略和临床翻译上.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.